Joy D. Scheidell, PhD, MPH
University of Central Florida - Assistant Professor, Department of Health Sciences
Email: Joy.Scheidell@ucf.edu
Education
PhD, Epidemiology, New York UniversityMPH, Epidemiology, University of Florida
BS, Community Health, Florida Gulf Coast University
Research Interests
Sexual and reproductive health, criminal justice involvement, substance use, mental health, health inequities BIO
Joy Scheidell is an epidemiologist and Assistant Professor in the Department of Health Sciences at the University of Central Florida. She received her PhD in Epidemiology from NYU and an MPH in Epidemiology from the University of Florida. She is a former predoctoral fellow of the NIDA-funded Behavioral Sciences Training in Drug Abuse Research Program (T32 DA7233) and scholar in the NIDA Diversity Scholars Network 2022 cohort. Dr. Scheidell’s research seeks to understand the intersections of mental health, substance use, and sexual and reproductive health, with a specific focus on vulnerable and marginalized populations. In addition to conducting her research, Dr. Scheidell is a devoted instructor of epidemiologic and population health research methods. Projects
Principal Investigator, Drug Treatment as Disease Prevention: Reducing Sexually Transmitted Infection Risk among Women Who Use Drugs. Active
Principal Investigator, Influence of Substance Use Treatment and Harm Reduction Engagement on Sexual Health among People Who Use Illicit Opioids in New York City. Completed
Principal Investigator, Racial/Ethnic Inequities in Treatment for Women with Opioid Use Disorder and Associations with Health. Completed
Publications
Recent
Scheidell JD, Chueng T, Ciraldo K, Hervera B, Dakoulas S, Mahachi M, Bennett AS, Elliott LC (2024).
Reaching people who use drugs with sexual and reproductive healthcare through syringe services programs: Potential promise and missed opportunities
Harm Reduction Journal, 21 (1), 198. doi: 10.1186/s12954-024-01116-5. PMCID: PMC11566571.
Reaching people who use drugs with sexual and reproductive healthcare through syringe services programs: Potential promise and missed opportunities
Harm Reduction Journal, 21 (1), 198. doi: 10.1186/s12954-024-01116-5. PMCID: PMC11566571.
Khan MR, Acri M, Ban KF, Scheidell JD, Stevens ER, Manandhar-Sasaki P, Charles D, Chichetto NE, Crystal S, Gordon AJ, Marshall BDL, Edelman EJ, Justice AC, Braithwaite SR, Caniglia EC (2024).
Associations between reductions in depressive symptoms and reductions in pain and anxiety symptoms and substance use: Emulation of a randomized trial
AJPM Focus, 3 (5), 100258. doi: 10.1016/j.focus.2024.100258. PMCID: PMC11407062.
Associations between reductions in depressive symptoms and reductions in pain and anxiety symptoms and substance use: Emulation of a randomized trial
AJPM Focus, 3 (5), 100258. doi: 10.1016/j.focus.2024.100258. PMCID: PMC11407062.
Ban KF, Rogers E, Khan M, Scheidell J, Charles D, Bryant KJ, Justice AC, Braithwaite RS, Caniglia EC (2024).
Does smoking cessation reduce other substance use, psychiatric symptoms, and pain symptoms? Results from an emulated hypothetical randomized trial of US veterans
PLoS One, 19 (7), e0298576. doi: 10.1371/journal.pone.0298576. PMCID: PMC11221691.
Does smoking cessation reduce other substance use, psychiatric symptoms, and pain symptoms? Results from an emulated hypothetical randomized trial of US veterans
PLoS One, 19 (7), e0298576. doi: 10.1371/journal.pone.0298576. PMCID: PMC11221691.
Scheidell JD, Townsend TN, Zhou Q, Manandhar-Sasaki P, Rodriguez-Santana R, Jenkins M, Buchelli M, Charles DL, Frechette JM, Su JI, Braithwaite RS (2024).
Reducing overdose deaths among persons with opioid use disorder in Connecticut
Harm Reduction Journal, 21 (1), 103. doi: 10.1186/s12954-024-01026-6. PMCID: PMC11131266.
Reducing overdose deaths among persons with opioid use disorder in Connecticut
Harm Reduction Journal, 21 (1), 103. doi: 10.1186/s12954-024-01026-6. PMCID: PMC11131266.
Feelemyer J, Duncan DT, Akhidenor N, Mazumdar M, Irvine NM, Scheidell JD, Brewer RA, Turpin RE, Hucks-Ortiz C, Dyer TV, Cleland CM, Mayer KH, Khan MR (2024).
Police harassment and psychiatric, sexual, and substance use risk among Black sexual minority men and Black transgender women in the HIV Prevention Trials 061 cohort
Journal of Racial and Ethnic Health Disparities [Epub 2024 Apr 12]. doi: 10.1007/s40615-024-01909-1. PMCID: PMC11470103.
Police harassment and psychiatric, sexual, and substance use risk among Black sexual minority men and Black transgender women in the HIV Prevention Trials 061 cohort
Journal of Racial and Ethnic Health Disparities [Epub 2024 Apr 12]. doi: 10.1007/s40615-024-01909-1. PMCID: PMC11470103.
Notable
Borderline personality disorder symptom severity and sexually transmitted infection and HIV risk in African American incarcerated men
Sexually Transmitted Diseases, 43 (5), 317-323. doi: 10.1097/OLQ.0000000000000433. PMCID: PMC4840466.
Ms. Scheidell's MyBibliography Profile